Covid-19 Impact on Global Medical Isotopes Market Size, Status and Forecast 2020-2026

July 2020 | 133 pages | ID: C08D00F29AD6EN
QYResearch

Abstracts

Medical Isotopes market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Medical Isotopes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Medical Isotopes market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyzes the impact of Coronavirus COVID-19 on the Medical Isotopes industry.
The key players covered in this study

• JSC Isotope
• Cambridge Isotope Laboratories
• Center of Molecular Research
• Shanghai Engineering Research Center
• Urenco
• NHTC
• LANL
• Linde
• ORNL
• 3M (Ceradyne)
• Marshall Isotopes
• SI Science
• Bruce Power
• Rosatom
• China National Nuclear Corporation
• IRE
• Eckert Ziegler
• Epsilon Radioactive Sources
• NTP Radioisotopes
• International Isotopes Inc.

Market segment by Type, the product can be split into

• Stable Isotopes
• Radioisotopes

Market segment by Application, split into

• Hospital
• Clinical
• Santific Research

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Medical Isotopes status, future forecast, growth opportunity, key market and key players.
• To present the Medical Isotopes development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Medical Isotopes are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Medical Isotopes Revenue
1.4 Covid-19 Implications on Market by Type
  1.4.1 Global Medical Isotopes Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Stable Isotopes
  1.4.3 Radioisotopes
1.5 Market by Application
  1.5.1 Global Medical Isotopes Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Clinical
  1.5.4 Santific Research
1.6 Coronavirus Disease 2019 (Covid-19): Medical Isotopes Industry Impact
  1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
  1.6.2 Covid-19 Impact: Commodity Prices Indices
  1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Covid-19 Implications on Global Medical Isotopes Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global Medical Isotopes Growth Trends by Regions
  2.2.1 Medical Isotopes Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Medical Isotopes Historic Market Share by Regions (2015-2020)
  2.2.3 Medical Isotopes Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Medical Isotopes Market Growth Strategy
  2.3.6 Primary Interviews with Key Medical Isotopes Players (Opinion Leaders)

3 COVID-19 IMPLICATIONS ON COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Medical Isotopes Players by Market Size
  3.1.1 Global Top Medical Isotopes Players by Revenue (2015-2020)
  3.1.2 Global Medical Isotopes Revenue Market Share by Players (2015-2020)
  3.1.3 Global Medical Isotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Medical Isotopes Market Concentration Ratio
  3.2.1 Global Medical Isotopes Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Medical Isotopes Revenue in 2019
3.3 Medical Isotopes Key Players Head office and Area Served
3.4 Key Players Medical Isotopes Product Solution and Service
3.5 Date of Enter into Medical Isotopes Market
3.6 Mergers & Acquisitions, Expansion Plans

4 COVID-19 IMPLICATIONS ON MARKET SIZE BY TYPE (2015-2026)

4.1 Global Medical Isotopes Historic Market Size by Type (2015-2020)
4.2 Global Medical Isotopes Forecasted Market Size by Type (2021-2026)

5 COVID-19 IMPLICATIONS ON MARKET SIZE BY APPLICATION (2015-2026)

5.1 Global Medical Isotopes Market Size by Application (2015-2020)
5.2 Global Medical Isotopes Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA IMPACT OF COVID-19

6.1 North America Medical Isotopes Market Size (2015-2020)
6.2 Medical Isotopes Key Players in North America (2019-2020)
6.3 North America Medical Isotopes Market Size by Type (2015-2020)
6.4 North America Medical Isotopes Market Size by Application (2015-2020)

7 EUROPE IMPACT OF COVID-19

7.1 Europe Medical Isotopes Market Size (2015-2020)
7.2 Medical Isotopes Key Players in Europe (2019-2020)
7.3 Europe Medical Isotopes Market Size by Type (2015-2020)
7.4 Europe Medical Isotopes Market Size by Application (2015-2020)

8 CHINA IMPACT OF COVID-19

8.1 China Medical Isotopes Market Size (2015-2020)
8.2 Medical Isotopes Key Players in China (2019-2020)
8.3 China Medical Isotopes Market Size by Type (2015-2020)
8.4 China Medical Isotopes Market Size by Application (2015-2020)

9 JAPAN IMPACT OF COVID-19

9.1 Japan Medical Isotopes Market Size (2015-2020)
9.2 Medical Isotopes Key Players in Japan (2019-2020)
9.3 Japan Medical Isotopes Market Size by Type (2015-2020)
9.4 Japan Medical Isotopes Market Size by Application (2015-2020)

10 SOUTHEAST ASIA IMPACT OF COVID-19

10.1 Southeast Asia Medical Isotopes Market Size (2015-2020)
10.2 Medical Isotopes Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Medical Isotopes Market Size by Type (2015-2020)
10.4 Southeast Asia Medical Isotopes Market Size by Application (2015-2020)

11 INDIA IMPACT OF COVID-19

11.1 India Medical Isotopes Market Size (2015-2020)
11.2 Medical Isotopes Key Players in India (2019-2020)
11.3 India Medical Isotopes Market Size by Type (2015-2020)
11.4 India Medical Isotopes Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA IMPACT OF COVID-19

12.1 Central & South America Medical Isotopes Market Size (2015-2020)
12.2 Medical Isotopes Key Players in Central & South America (2019-2020)
12.3 Central & South America Medical Isotopes Market Size by Type (2015-2020)
12.4 Central & South America Medical Isotopes Market Size by Application (2015-2020)

13KEY PLAYERS PROFILES

13.1 JSC Isotope
  13.1.1 JSC Isotope Company Details
  13.1.2 JSC Isotope Business Overview and Its Total Revenue
  13.1.3 JSC Isotope Medical Isotopes Introduction
  13.1.4 JSC Isotope Revenue in Medical Isotopes Business (2015-2020))
  13.1.5 JSC Isotope Recent Development and Reaction to COVID-19
13.2 Cambridge Isotope Laboratories
  13.2.1 Cambridge Isotope Laboratories Company Details
  13.2.2 Cambridge Isotope Laboratories Business Overview and Its Total Revenue
  13.2.3 Cambridge Isotope Laboratories Medical Isotopes Introduction
  13.2.4 Cambridge Isotope Laboratories Revenue in Medical Isotopes Business (2015-2020)
  13.2.5 Cambridge Isotope Laboratories Recent Development and Reaction to COVID-19
13.3 Center of Molecular Research
  13.3.1 Center of Molecular Research Company Details
  13.3.2 Center of Molecular Research Business Overview and Its Total Revenue
  13.3.3 Center of Molecular Research Medical Isotopes Introduction
  13.3.4 Center of Molecular Research Revenue in Medical Isotopes Business (2015-2020)
  13.3.5 Center of Molecular Research Recent Development and Reaction to COVID-19
13.4 Shanghai Engineering Research Center
  13.4.1 Shanghai Engineering Research Center Company Details
  13.4.2 Shanghai Engineering Research Center Business Overview and Its Total Revenue
  13.4.3 Shanghai Engineering Research Center Medical Isotopes Introduction
  13.4.4 Shanghai Engineering Research Center Revenue in Medical Isotopes Business (2015-2020)
  13.4.5 Shanghai Engineering Research Center Recent Development and Reaction to COVID-19
13.5 Urenco
  13.5.1 Urenco Company Details
  13.5.2 Urenco Business Overview and Its Total Revenue
  13.5.3 Urenco Medical Isotopes Introduction
  13.5.4 Urenco Revenue in Medical Isotopes Business (2015-2020)
  13.5.5 Urenco Recent Development and Reaction to COVID-19
13.6 NHTC
  13.6.1 NHTC Company Details
  13.6.2 NHTC Business Overview and Its Total Revenue
  13.6.3 NHTC Medical Isotopes Introduction
  13.6.4 NHTC Revenue in Medical Isotopes Business (2015-2020)
  13.6.5 NHTC Recent Development and Reaction to COVID-19
13.7 LANL
  13.7.1 LANL Company Details
  13.7.2 LANL Business Overview and Its Total Revenue
  13.7.3 LANL Medical Isotopes Introduction
  13.7.4 LANL Revenue in Medical Isotopes Business (2015-2020)
  13.7.5 LANL Recent Development and Reaction to COVID-19
13.8 Linde
  13.8.1 Linde Company Details
  13.8.2 Linde Business Overview and Its Total Revenue
  13.8.3 Linde Medical Isotopes Introduction
  13.8.4 Linde Revenue in Medical Isotopes Business (2015-2020)
  13.8.5 Linde Recent Development and Reaction to COVID-19
13.9 ORNL
  13.9.1 ORNL Company Details
  13.9.2 ORNL Business Overview and Its Total Revenue
  13.9.3 ORNL Medical Isotopes Introduction
  13.9.4 ORNL Revenue in Medical Isotopes Business (2015-2020)
  13.9.5 ORNL Recent Development and Reaction to COVID-19
13.10 3M (Ceradyne)
  13.10.1 3M (Ceradyne) Company Details
  13.10.2 3M (Ceradyne) Business Overview and Its Total Revenue
  13.10.3 3M (Ceradyne) Medical Isotopes Introduction
  13.10.4 3M (Ceradyne) Revenue in Medical Isotopes Business (2015-2020)
  13.10.5 3M (Ceradyne) Recent Development and Reaction to COVID-19
13.11 Marshall Isotopes
  10.11.1 Marshall Isotopes Company Details
  10.11.2 Marshall Isotopes Business Overview and Its Total Revenue
  10.11.3 Marshall Isotopes Medical Isotopes Introduction
  10.11.4 Marshall Isotopes Revenue in Medical Isotopes Business (2015-2020)
  10.11.5 Marshall Isotopes Recent Development and Reaction to COVID-19
13.12 SI Science
  10.12.1 SI Science Company Details
  10.12.2 SI Science Business Overview and Its Total Revenue
  10.12.3 SI Science Medical Isotopes Introduction
  10.12.4 SI Science Revenue in Medical Isotopes Business (2015-2020)
  10.12.5 SI Science Recent Development and Reaction to COVID-19
13.13 Bruce Power
  10.13.1 Bruce Power Company Details
  10.13.2 Bruce Power Business Overview and Its Total Revenue
  10.13.3 Bruce Power Medical Isotopes Introduction
  10.13.4 Bruce Power Revenue in Medical Isotopes Business (2015-2020)
  10.13.5 Bruce Power Recent Development and Reaction to COVID-19
13.14 Rosatom
  10.14.1 Rosatom Company Details
  10.14.2 Rosatom Business Overview and Its Total Revenue
  10.14.3 Rosatom Medical Isotopes Introduction
  10.14.4 Rosatom Revenue in Medical Isotopes Business (2015-2020)
  10.14.5 Rosatom Recent Development and Reaction to COVID-19
13.15 China National Nuclear Corporation
  10.15.1 China National Nuclear Corporation Company Details
  10.15.2 China National Nuclear Corporation Business Overview and Its Total Revenue
  10.15.3 China National Nuclear Corporation Medical Isotopes Introduction
  10.15.4 China National Nuclear Corporation Revenue in Medical Isotopes Business (2015-2020)
  10.15.5 China National Nuclear Corporation Recent Development and Reaction to COVID-19
13.16 IRE
  10.16.1 IRE Company Details
  10.16.2 IRE Business Overview and Its Total Revenue
  10.16.3 IRE Medical Isotopes Introduction
  10.16.4 IRE Revenue in Medical Isotopes Business (2015-2020)
  10.16.5 IRE Recent Development and Reaction to COVID-19
13.17 Eckert Ziegler
  10.17.1 Eckert Ziegler Company Details
  10.17.2 Eckert Ziegler Business Overview and Its Total Revenue
  10.17.3 Eckert Ziegler Medical Isotopes Introduction
  10.17.4 Eckert Ziegler Revenue in Medical Isotopes Business (2015-2020)
  10.17.5 Eckert Ziegler Recent Development and Reaction to COVID-19
13.18 Epsilon Radioactive Sources
  10.18.1 Epsilon Radioactive Sources Company Details
  10.18.2 Epsilon Radioactive Sources Business Overview and Its Total Revenue
  10.18.3 Epsilon Radioactive Sources Medical Isotopes Introduction
  10.18.4 Epsilon Radioactive Sources Revenue in Medical Isotopes Business (2015-2020)
  10.18.5 Epsilon Radioactive Sources Recent Development and Reaction to COVID-19
13.19 NTP Radioisotopes
  10.19.1 NTP Radioisotopes Company Details
  10.19.2 NTP Radioisotopes Business Overview and Its Total Revenue
  10.19.3 NTP Radioisotopes Medical Isotopes Introduction
  10.19.4 NTP Radioisotopes Revenue in Medical Isotopes Business (2015-2020)
  10.19.5 NTP Radioisotopes Recent Development and Reaction to COVID-19
13.20 International Isotopes Inc.
  10.20.1 International Isotopes Inc. Company Details
  10.20.2 International Isotopes Inc. Business Overview and Its Total Revenue
  10.20.3 International Isotopes Inc. Medical Isotopes Introduction
  10.20.4 International Isotopes Inc. Revenue in Medical Isotopes Business (2015-2020)
  10.20.5 International Isotopes Inc. Recent Development and Reaction to COVID-19

14ANALYST'S VIEWPOINTS/CONCLUSIONS

15APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Medical Isotopes Key Market Segments
Table 2. Key Players Covered: Ranking by Medical Isotopes Revenue
Table 3. Ranking of Global Top Medical Isotopes Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Medical Isotopes Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Stable Isotopes
Table 6. Key Players of Radioisotopes
Table 7. COVID-19 Impact Global Market: (Four Medical Isotopes Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Medical Isotopes Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Medical Isotopes Players to Combat Covid-19 Impact
Table 12. Global Medical Isotopes Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Medical Isotopes Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Medical Isotopes Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Medical Isotopes Market Share by Regions (2015-2020)
Table 16. Global Medical Isotopes Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Medical Isotopes Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Medical Isotopes Market Growth Strategy
Table 22. Main Points Interviewed from Key Medical Isotopes Players
Table 23. Global Medical Isotopes Revenue by Players (2015-2020) (Million US$)
Table 24. Global Medical Isotopes Market Share by Players (2015-2020)
Table 25. Global Top Medical Isotopes Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Medical Isotopes as of 2019)
Table 26. Global Medical Isotopes by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Medical Isotopes Product Solution and Service
Table 29. Date of Enter into Medical Isotopes Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Medical Isotopes Market Size by Type (2015-2020) (Million US$)
Table 32. Global Medical Isotopes Market Size Share by Type (2015-2020)
Table 33. Global Medical Isotopes Revenue Market Share by Type (2021-2026)
Table 34. Global Medical Isotopes Market Size Share by Application (2015-2020)
Table 35. Global Medical Isotopes Market Size by Application (2015-2020) (Million US$)
Table 36. Global Medical Isotopes Market Size Share by Application (2021-2026)
Table 37. North America Key Players Medical Isotopes Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Medical Isotopes Market Share (2019-2020)
Table 39. North America Medical Isotopes Market Size by Type (2015-2020) (Million US$)
Table 40. North America Medical Isotopes Market Share by Type (2015-2020)
Table 41. North America Medical Isotopes Market Size by Application (2015-2020) (Million US$)
Table 42. North America Medical Isotopes Market Share by Application (2015-2020)
Table 43. Europe Key Players Medical Isotopes Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Medical Isotopes Market Share (2019-2020)
Table 45. Europe Medical Isotopes Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Medical Isotopes Market Share by Type (2015-2020)
Table 47. Europe Medical Isotopes Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Medical Isotopes Market Share by Application (2015-2020)
Table 49. China Key Players Medical Isotopes Revenue (2019-2020) (Million US$)
Table 50. China Key Players Medical Isotopes Market Share (2019-2020)
Table 51. China Medical Isotopes Market Size by Type (2015-2020) (Million US$)
Table 52. China Medical Isotopes Market Share by Type (2015-2020)
Table 53. China Medical Isotopes Market Size by Application (2015-2020) (Million US$)
Table 54. China Medical Isotopes Market Share by Application (2015-2020)
Table 55. Japan Key Players Medical Isotopes Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Medical Isotopes Market Share (2019-2020)
Table 57. Japan Medical Isotopes Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Medical Isotopes Market Share by Type (2015-2020)
Table 59. Japan Medical Isotopes Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Medical Isotopes Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Medical Isotopes Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Medical Isotopes Market Share (2019-2020)
Table 63. Southeast Asia Medical Isotopes Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Medical Isotopes Market Share by Type (2015-2020)
Table 65. Southeast Asia Medical Isotopes Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Medical Isotopes Market Share by Application (2015-2020)
Table 67. India Key Players Medical Isotopes Revenue (2019-2020) (Million US$)
Table 68. India Key Players Medical Isotopes Market Share (2019-2020)
Table 69. India Medical Isotopes Market Size by Type (2015-2020) (Million US$)
Table 70. India Medical Isotopes Market Share by Type (2015-2020)
Table 71. India Medical Isotopes Market Size by Application (2015-2020) (Million US$)
Table 72. India Medical Isotopes Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Medical Isotopes Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Medical Isotopes Market Share (2019-2020)
Table 75. Central & South America Medical Isotopes Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Medical Isotopes Market Share by Type (2015-2020)
Table 77. Central & South America Medical Isotopes Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Medical Isotopes Market Share by Application (2015-2020)
Table 79. JSC Isotope Company Details
Table 80. JSC Isotope Business Overview
Table 81. JSC Isotope Product
Table 82. JSC Isotope Revenue in Medical Isotopes Business (2015-2020) (Million US$)
Table 83. JSC Isotope Recent Development
Table 84. Cambridge Isotope Laboratories Company Details
Table 85. Cambridge Isotope Laboratories Business Overview
Table 86. Cambridge Isotope Laboratories Product
Table 87. Cambridge Isotope Laboratories Revenue in Medical Isotopes Business (2015-2020) (Million US$)
Table 88. Cambridge Isotope Laboratories Recent Development
Table 89. Center of Molecular Research Company Details
Table 90. Center of Molecular Research Business Overview
Table 91. Center of Molecular Research Product
Table 92. Center of Molecular Research Revenue in Medical Isotopes Business (2015-2020) (Million US$)
Table 93. Center of Molecular Research Recent Development
Table 94. Shanghai Engineering Research Center Company Details
Table 95. Shanghai Engineering Research Center Business Overview
Table 96. Shanghai Engineering Research Center Product
Table 97. Shanghai Engineering Research Center Revenue in Medical Isotopes Business (2015-2020) (Million US$)
Table 98. Shanghai Engineering Research Center Recent Development
Table 99. Urenco Company Details
Table 100. Urenco Business Overview
Table 101. Urenco Product
Table 102. Urenco Revenue in Medical Isotopes Business (2015-2020) (Million US$)
Table 103. Urenco Recent Development
Table 104. NHTC Company Details
Table 105. NHTC Business Overview
Table 106. NHTC Product
Table 107. NHTC Revenue in Medical Isotopes Business (2015-2020) (Million US$)
Table 108. NHTC Recent Development
Table 109. LANL Company Details
Table 110. LANL Business Overview
Table 111. LANL Product
Table 112. LANL Revenue in Medical Isotopes Business (2015-2020) (Million US$)
Table 113. LANL Recent Development
Table 114. Linde Business Overview
Table 115. Linde Product
Table 116. Linde Company Details
Table 117. Linde Revenue in Medical Isotopes Business (2015-2020) (Million US$)
Table 118. Linde Recent Development
Table 119. ORNL Company Details
Table 120. ORNL Business Overview
Table 121. ORNL Product
Table 122. ORNL Revenue in Medical Isotopes Business (2015-2020) (Million US$)
Table 123. ORNL Recent Development
Table 124. 3M (Ceradyne) Company Details
Table 125. 3M (Ceradyne) Business Overview
Table 126. 3M (Ceradyne) Product
Table 127. 3M (Ceradyne) Revenue in Medical Isotopes Business (2015-2020) (Million US$)
Table 128. 3M (Ceradyne) Recent Development
Table 129. Marshall Isotopes Company Details
Table 130. Marshall Isotopes Business Overview
Table 131. Marshall Isotopes Product
Table 132. Marshall Isotopes Revenue in Medical Isotopes Business (2015-2020) (Million US$)
Table 133. Marshall Isotopes Recent Development
Table 134. SI Science Company Details
Table 135. SI Science Business Overview
Table 136. SI Science Product
Table 137. SI Science Revenue in Medical Isotopes Business (2015-2020) (Million US$)
Table 138. SI Science Recent Development
Table 139. Bruce Power Company Details
Table 140. Bruce Power Business Overview
Table 141. Bruce Power Product
Table 142. Bruce Power Revenue in Medical Isotopes Business (2015-2020) (Million US$)
Table 143. Bruce Power Recent Development
Table 144. Rosatom Company Details
Table 145. Rosatom Business Overview
Table 146. Rosatom Product
Table 147. Rosatom Revenue in Medical Isotopes Business (2015-2020) (Million US$)
Table 148. Rosatom Recent Development
Table 149. China National Nuclear Corporation Company Details
Table 150. China National Nuclear Corporation Business Overview
Table 151. China National Nuclear Corporation Product
Table 152. China National Nuclear Corporation Revenue in Medical Isotopes Business (2015-2020) (Million US$)
Table 153. China National Nuclear Corporation Recent Development
Table 154. IRE Company Details
Table 155. IRE Business Overview
Table 156. IRE Product
Table 157. IRE Revenue in Medical Isotopes Business (2015-2020) (Million US$)
Table 158. IRE Recent Development
Table 159. Eckert Ziegler Company Details
Table 160. Eckert Ziegler Business Overview
Table 161. Eckert Ziegler Product
Table 162. Eckert Ziegler Revenue in Medical Isotopes Business (2015-2020) (Million US$)
Table 163. Eckert Ziegler Recent Development
Table 164. Epsilon Radioactive Sources Company Details
Table 165. Epsilon Radioactive Sources Business Overview
Table 166. Epsilon Radioactive Sources Product
Table 167. Epsilon Radioactive Sources Revenue in Medical Isotopes Business (2015-2020) (Million US$)
Table 168. Epsilon Radioactive Sources Recent Development
Table 169. NTP Radioisotopes Company Details
Table 170. NTP Radioisotopes Business Overview
Table 171. NTP Radioisotopes Product
Table 172. NTP Radioisotopes Revenue in Medical Isotopes Business (2015-2020) (Million US$)
Table 173. NTP Radioisotopes Recent Development
Table 174. International Isotopes Inc. Company Details
Table 175. International Isotopes Inc. Business Overview
Table 176. International Isotopes Inc. Product
Table 177. International Isotopes Inc. Revenue in Medical Isotopes Business (2015-2020) (Million US$)
Table 178. International Isotopes Inc. Recent Development
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Medical Isotopes Market Share by Type: 2020 VS 2026
Figure 2. Stable Isotopes Features
Figure 3. Radioisotopes Features
Figure 4. Global Medical Isotopes Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Clinical Case Studies
Figure 7. Santific Research Case Studies
Figure 8. Medical Isotopes Report Years Considered
Figure 9. Global Medical Isotopes Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Medical Isotopes Market Share by Regions: 2020 VS 2026
Figure 11. Global Medical Isotopes Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Medical Isotopes Market Share by Players in 2019
Figure 14. Global Top Medical Isotopes Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Medical Isotopes as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Medical Isotopes Revenue in 2019
Figure 16. North America Medical Isotopes Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Medical Isotopes Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Medical Isotopes Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Medical Isotopes Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Medical Isotopes Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Medical Isotopes Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Medical Isotopes Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. JSC Isotope Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. JSC Isotope Revenue Growth Rate in Medical Isotopes Business (2015-2020)
Figure 25. Cambridge Isotope Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Cambridge Isotope Laboratories Revenue Growth Rate in Medical Isotopes Business (2015-2020)
Figure 27. Center of Molecular Research Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Center of Molecular Research Revenue Growth Rate in Medical Isotopes Business (2015-2020)
Figure 29. Shanghai Engineering Research Center Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Shanghai Engineering Research Center Revenue Growth Rate in Medical Isotopes Business (2015-2020)
Figure 31. Urenco Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Urenco Revenue Growth Rate in Medical Isotopes Business (2015-2020)
Figure 33. NHTC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. NHTC Revenue Growth Rate in Medical Isotopes Business (2015-2020)
Figure 35. LANL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. LANL Revenue Growth Rate in Medical Isotopes Business (2015-2020)
Figure 37. Linde Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Linde Revenue Growth Rate in Medical Isotopes Business (2015-2020)
Figure 39. ORNL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. ORNL Revenue Growth Rate in Medical Isotopes Business (2015-2020)
Figure 41. 3M (Ceradyne) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. 3M (Ceradyne) Revenue Growth Rate in Medical Isotopes Business (2015-2020)
Figure 43. Marshall Isotopes Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Marshall Isotopes Revenue Growth Rate in Medical Isotopes Business (2015-2020)
Figure 45. SI Science Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. SI Science Revenue Growth Rate in Medical Isotopes Business (2015-2020)
Figure 47. Bruce Power Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Bruce Power Revenue Growth Rate in Medical Isotopes Business (2015-2020)
Figure 49. Rosatom Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Rosatom Revenue Growth Rate in Medical Isotopes Business (2015-2020)
Figure 51. China National Nuclear Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. China National Nuclear Corporation Revenue Growth Rate in Medical Isotopes Business (2015-2020)
Figure 53. IRE Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. IRE Revenue Growth Rate in Medical Isotopes Business (2015-2020)
Figure 55. Eckert Ziegler Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Eckert Ziegler Revenue Growth Rate in Medical Isotopes Business (2015-2020)
Figure 57. Epsilon Radioactive Sources Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Epsilon Radioactive Sources Revenue Growth Rate in Medical Isotopes Business (2015-2020)
Figure 59. NTP Radioisotopes Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. NTP Radioisotopes Revenue Growth Rate in Medical Isotopes Business (2015-2020)
Figure 61. International Isotopes Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. International Isotopes Inc. Revenue Growth Rate in Medical Isotopes Business (2015-2020)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed